Skip to main content
Log in

Increased incidence of neutralizing autoantibodies against interleukin-1α (IL-1α) in nondestructive chronic polyarthritis

  • Original Articles
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Cytokines such as IL-1 and tumor necrosis factor a (TNFa) play a critical role in chronic joint inflammation and destruction. To study their regulation, we looked for circulating antiproinflammatory cytokine autoantibodies in 318 patients with chronic arthritis by immunoprecipitation with protein G. Anti-IL-1α but not anti-IL-1β or anti-TNFα IgG antibodies were detected in 9% of blood donors and 18.9% of chronic arthritis patients. These antibodies were found more commonly and at a higher level in patients with nondestructive arthritis. Negative correlations were observed between the antibody levels and indices of disease activity and joint destruction. There was a negative association between the presence of anti-IL-1α antibodies and that of HLA-DR4. These circulating anti-IL-1α antibodies were not complexed with IL-1α and could block specifically the biological activity of IL-1α and its binding to membrane IL-1 receptors. These results indicate that these antibodies are beneficial, suggesting their contribution in the clinical presentation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brennan FM, Maini RN, Feldmann M: TNF alpha: A pivotal role in rheumatoid arthritis? Br J Rheumatol 31:293–298, 1992

    PubMed  Google Scholar 

  2. Miossec P: Cytokine abnormalities in inflammatory arthritis.In New Developments in Investigation and Management of Early Inflammatory Arthritis, P Emery (ed). London, Ballière Tindall, 1992, pp 373–392

    Google Scholar 

  3. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factorα (cA2) versus placebo in rheumatoid arthritis. Lancet 344:1105–1110, 1994

    PubMed  Google Scholar 

  4. Arend WP, Dayer JM: Inhibition of the production and effects of interleukin-1 and tumor necrosis factorα in rheumatoid arthritis. Arth Rheum 38:151–160, 1995

    Google Scholar 

  5. Dinarello CA: The interleukin-1 family: 10 years of discovery. FASEB J 8:1314–1325, 1994

    PubMed  Google Scholar 

  6. Bendtzen K, Svenson M, Jonsson V, Hippe E: Autoantibodies to cytokines: Friends or foes? Immunol Today 11:167–169, 1990

    PubMed  Google Scholar 

  7. Svenson M, Poulsen LK, Fomsgaard A, Bendtzen K: IgG autoantibodies against interleukin 1α in sera of normal individuals. Scand J Immunol 29:489–492, 1989

    PubMed  Google Scholar 

  8. Gallay P, Mach J-P, Carrel S: Characterization and detection of naturally occurring antibodies against IL-1α and IL-1β in normal human plasma. Eur Cytokine Netw 2:329–338, 1991

    PubMed  Google Scholar 

  9. Hansen MB, Svenson M, Bendtzen K: Human anti-interleukin 1α antibodies. Immunol Lett 30:133–140, 1991

    PubMed  Google Scholar 

  10. Saurat JH, Schifferli J, Steiger G, Dayer JM, Didierjean L: Anti-interleukin-1α autoantibodies in humans: Characterization, isotype distribution, and receptor-binding inhibition. Higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia). J Allergy Clin Immunol 88:244–256, 1991

    PubMed  Google Scholar 

  11. Svenson M, Hansen MB, Bendtzen K: Binding of cytokines to pharmaceutically prepared human immunoglobulin. J Clin Invest 92:2533–2539, 1993

    PubMed  Google Scholar 

  12. Suzuki H, Akama T, Okane M, Kono I, Matsui Y, Yamane K, Kashiwagi H: Interleukin-1-inhibitory IgG in sera from some patients with rheumatoid arthritis. Arth Rheum 32:1528–1538, 1989

    Google Scholar 

  13. Suzuki H, Kamimura J, Ayabe T, Kashiwagi H: Demonstration of neutralizing autoantibodies against IL-1α in sera from patients with rheumatoid arthritis. J Immunol 145:2140–2146, 1990

    PubMed  Google Scholar 

  14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Pries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Nenstadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GC: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arth Rheum 31:315–324, 1988

    Google Scholar 

  15. Greenspan JS, Daniels TE, Talal N, Sylvester RA: The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg 37:217–229, 1974

    PubMed  Google Scholar 

  16. Tunn EJ, Bacon PA: Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheum 32:97–103, 1993

    Google Scholar 

  17. Grassi J, Roberge CJ, Frobert Y, PP, Poubelle PE: Determination of IL1α, IL1β in biological media using specific enzyme immunometric assays. Immunol Rev 119:125–145, 1991

    PubMed  Google Scholar 

  18. Beuscher HU, Rausch U-P, Otterness IG, Röllinghoff M: Transition from Interleukin 1β (IL-1β) to IL-1α production during maturation of inflammatory macrophages in vivo. J Exp Med 175:1793–1797, 1992

    PubMed  Google Scholar 

  19. Deleuran BW, Chu CQ, Field M, Brennan FM, Katsikis P, Feldmann M, Maini RN: Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol 31:801–809, 1992

    PubMed  Google Scholar 

  20. Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN: Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: Implications for the role of cytokines in cartilage destruction and repair. Br J Rheum 31:653–661, 1992

    Google Scholar 

  21. Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M: Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1α. Clin Exp Immunol 73:449–455, 1988

    PubMed  Google Scholar 

  22. Van de Loo AAJ, Arntz OJ, Bakker AC, Van Lent PLEM, Jacobs MM, Van den Berg WB: Role of interleukin 1 in antigen-induced exacerbations of murine arthritis. Am J Pathol 146:239–249, 1995

    PubMed  Google Scholar 

  23. Garonne P, Djossou O, Fossiez F, Reyes J, Ait-Yahia S, Maat C, Ho S, Hauser T, Dayer JM, Miossec P, Lebeque S, Rousset F, Banchereau J: Generation of a human monoclonal autoantibody that acts as a high affinity IL-1α specific inhibitor. Mol Immunol 33:649–658, 1996

    PubMed  Google Scholar 

  24. Williams RO, Mason LJ, Feldmann M, Maini RM: Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci USA 91:2762–2766, 1994

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jouvenne, P., Fossiez, F., Garrone, P. et al. Increased incidence of neutralizing autoantibodies against interleukin-1α (IL-1α) in nondestructive chronic polyarthritis. J Clin Immunol 16, 283–290 (1996). https://doi.org/10.1007/BF01541394

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01541394

Key words

Navigation